Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06477588 · ClinicalTrials.gov registry record · NA

J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations

A NA study of HIV and Substance Use, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT06477588: Recruiting NA study of HIV and Substance Use, sponsored by University of Chicago.

NCT06477588 is a NA study of HIV and Substance Use that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 350 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06477588, a NA study of HIV and Substance Use, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare two interventions - Health Navigation and Health Navigation Plus among individuals who have been impacted by the criminal legal system. The main question it aims to answer is: • Compared with the Health Navigation group, are participants in the Health Navigation Plus group more likely to a) access HIV care, treatment, and prevention services and employment services and b) access employment services and be employed in community? Participants on the study will be: * Randomly assigned (like a flip of a coin) to participate in either Health Navigation or Health Navigation Plus. Participants will have an equal chance of being placed in either group. * Complete three surveys over the course of 13 months * Participants in the Health Navigation group will have two in person meetings and seven check-ins with the health navigator over 6 months * Participants in the Health Navigation Plus group will have two in person meetings and seven check-ins with the health navigator over 6 months, two in person and 10 check ins with the employment navigator over 12 months and up to $200 to support employment and career development needs and receive up to $140 to support health goals. Samples of blood, urine and swabs may be collected to meet the health goals.

Primary Outcome

Number of participants who visit a provider for HIV care and receive a prescription based on medical reports

Interventions

  • BEHAVIORAL Health Navigation
  • BEHAVIORAL Health Navigation, Employment Navigation plus Contingency Management Intervention

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2024-08-13
Est. Completion 2028-06-30
Phase NA
University of Chicago

796 total trials

What NCT06477588 shows while recruiting

NCT06477588 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (20% lower).

The record links to 6 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Health Navigation is the first listed.

NCT06477588 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06477588 about?

NCT06477588 is a clinical study titled "J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations". The goal of this clinical trial is to compare two interventions - Health Navigation and Health Navigation Plus among individuals who have been impacted by the criminal legal system. The main question it aims to answer is: • Compared with the Health Navigation group, are participants in the Health ...

What is the current status of trial NCT06477588?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2024-08-13. Estimated completion is 2028-06-30.

What conditions does trial NCT06477588 study?

This clinical trial studies the following conditions: HIV, Substance Use, Mental Health, Contingency Management, Justice Involved Populations.

What interventions are being tested in trial NCT06477588?

The interventions under investigation include: Health Navigation (BEHAVIORAL), Health Navigation, Employment Navigation plus Contingency Management Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06477588?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06477588 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06477588's enrollment target sits among peer trials

350 61st of 303 higher than 243 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06477588, the US trial registry maintained by the National Library of Medicine. NCT06477588 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.